Neratinib(Nerlynx)

Release date: 2026-01-05 14:06:38     Recommended: 29

It is indicated for the treatment of early-stage and advanced-stage HER2-positive breast cancer, and can be used as a monotherapy for adjuvant treatment or in combination with capecitabine for metasta